These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
152 related items for PubMed ID: 8370369
1. A potassium channel opener as monotherapy in chronic stable angina pectoris: comparison with placebo. Why HJ, Richardson PJ. Eur Heart J; 1993 Jul; 14 Suppl B():25-9. PubMed ID: 8370369 [Abstract] [Full Text] [Related]
2. A double-blind comparison of the long-term efficacy of a potassium channel opener and a calcium antagonist in stable angina pectoris. Guermonprez JL, Blin P, Peterlongo F. Eur Heart J; 1993 Jul; 14 Suppl B():30-4. PubMed ID: 8370370 [Abstract] [Full Text] [Related]
3. A double-blind comparison of a beta-blocker and a potassium channel opener in exercise induced angina. Raftery EB, Lahiri A, Hughes LO, Rose EL. Eur Heart J; 1993 Jul; 14 Suppl B():35-9. PubMed ID: 8370371 [Abstract] [Full Text] [Related]
4. Haemodynamic and clinical effects of an intravenous potassium channel opener--a review. Kato K. Eur Heart J; 1993 Jul; 14 Suppl B():40-7. PubMed ID: 8370372 [Abstract] [Full Text] [Related]
5. Safety profile of an anti-anginal agent with potassium channel opening activity: an overview. Roland E. Eur Heart J; 1993 Jul; 14 Suppl B():48-52. PubMed ID: 8370373 [Abstract] [Full Text] [Related]
7. Nicorandil. A review of its pharmacology and therapeutic efficacy in angina pectoris. Frampton J, Buckley MM, Fitton A. Drugs; 1992 Oct; 44(4):625-55. PubMed ID: 1281076 [Abstract] [Full Text] [Related]
14. Comparison of nicorandil and atenolol in stable angina pectoris. Hughes LO, Rose EL, Lahiri A, Raftery EB. Am J Cardiol; 1990 Sep 15; 66(7):679-82. PubMed ID: 2144705 [Abstract] [Full Text] [Related]
17. Clinical profile of nicorandil: an overview of its hemodynamic properties and therapeutic efficacy. Krumenacker M, Roland E. J Cardiovasc Pharmacol; 1992 Sep 15; 20 Suppl 3():S93-102. PubMed ID: 1282184 [Abstract] [Full Text] [Related]
18. Nicorandil. An updated review of its use in ischaemic heart disease with emphasis on its cardioprotective effects. Markham A, Plosker GL, Goa KL. Drugs; 2000 Oct 15; 60(4):955-74. PubMed ID: 11085202 [Abstract] [Full Text] [Related]
19. A controlled single-dose study of the efficacy, dose response and duration of action of nicorandil in angina pectoris. Camm AJ, Maltz MB. Am J Cardiol; 1989 Jun 20; 63(21):61J-65J. PubMed ID: 2525328 [Abstract] [Full Text] [Related]
20. Effectiveness of nicorandil (SG-75), a new long-acting drug with nitroglycerin effects, in patients with coronary artery disease: improved left ventricular function and regional wall motion and abolition of pacing-induced angina. Thormann J, Schlepper M, Kramer W, Gottwik M, Kindler M. J Cardiovasc Pharmacol; 1983 Jun 20; 5(3):371-7. PubMed ID: 6191134 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]